At a glance
- Originator Dompe SpA
- Class Amines; Aminobutyric acids; Analgesics; Antiepileptic drugs; Antimanics; Antiparkinsonians; Anxiolytics; Cyclohexanecarboxylic acids; Gabapentinoids; Small molecules
- Mechanism of Action CACNA2D1 protein modulators; GABA receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Cancer pain
Most Recent Events
- 18 Feb 2022 Discontinued - Phase-III for Cancer pain (In adolescents, In children, In infants, In neonates) in Italy (PO)
- 19 Jul 2016 Chemical structure information added
- 19 Jul 2016 Phase-III clinical trials in Cancer pain (In adolescents, In children, In infants, In neonates) in Italy (PO)